Funds and ETFs Nanjing Vazyme Biotech Co.,Ltd

Equities

688105

CNE100004ZK3

Pharmaceuticals

End-of-day quote Shanghai S.E. 23:00:00 23/05/2024 BST 5-day change 1st Jan Change
23.49 CNY -1.30% Intraday chart for Nanjing Vazyme Biotech Co.,Ltd -5.78% -26.64%

ETFs positioned on Nanjing Vazyme Biotech Co.,Ltd

Name Weight AuM 1st Jan change Investor Rating
0.00% 34 M€ +4.20% -
Nanjing Vazyme Biotech Co Ltd is China-based company principally engaged in biopharmaceuticals. The Company's main business is the technology research and development and product development of functional proteins such as enzymes, antigens, antibodies, and polymer organic materials. The Company's products include polymerase chain reaction (PCR), reverse transcription, gene sequencing series and other biological reagent products, quantum dot immunofluorescence reagents, latex enhanced immune turbidity reagents and colloidal gold immunochromatography reagents and other point-of-care testing (POCT) Diagnostic reagents and instruments.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
23.49 CNY
Average target price
35.72 CNY
Spread / Average Target
+52.06%
Consensus
  1. Stock Market
  2. Equities
  3. 688105 Stock
  4. Funds and ETFs Nanjing Vazyme Biotech Co.,Ltd